| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChiefDERIV | Aug 12 | M | 1,650 | $0.00 | —? |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Aug 12 | F | 797 | $46.57 | $37K |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Aug 12 | M | 1,650 | $0.00 | — |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChiefDERIV | Jul 29 | A | 1,650 | $0.00 | —? |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChiefDERIV | Mar 6 | M | 3,750 | $0.00 | —? |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Mar 9 | S | 1,623 | $53.65 | $87K |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Mar 6 | F | 1,793 | $54.73 | $98K |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Mar 6 | M | 3,750 | $0.00 | — |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChiefDERIV | Feb 28 | A | 3,750 | $0.00 | —? |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChiefDERIV | Feb 25 | D | 1,875 | $0.00 | —? |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Feb 25 | F | 977 | $50.69 | $50K |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Feb 25 | A | 1,875 | $0.00 | — |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChiefDERIV | Feb 24 | D | 1,250 | $0.00 | —? |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChiefDERIV | Feb 24 | D | 750 | $0.00 | —? |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChiefDERIV | Feb 24 | D | 1,125 | $0.00 | —? |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Feb 24 | F | 670 | $50.86 | $34K |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Feb 24 | A | 1,250 | $0.00 | — |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Feb 24 | F | 368 | $50.86 | $19K |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Feb 24 | A | 750 | $0.00 | — |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Feb 24 | F | 603 | $51.35 | $31K |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChief | Feb 24 | A | 1,125 | $0.00 | — |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChiefDERIV | Feb 18 | A | 3,000 | $0.00 | —? |
| SUPERNUS PHARMACEUTICALS, INC. | SUPN | Frank MottolaChiefDERIV | Feb 18 | A | 13,500 | $0.00 | —? |